Increased erythrocyte resistance to osmotic lysis in the acute hepatitis caused by true hepatotropic viruses non-A, non-B (NANB)

被引:1
作者
Durgawale P. [1 ]
Shukla P.S. [1 ]
Mishra S. [2 ]
机构
[1] Department of Biochemistry, Krishna Institute of Medical Sciences
[2] Department of Pathology, Krishna Institute of Medical Sciences
关键词
Hemolysis; Osmotic fragility; Viral hepatitis;
D O I
10.1007/BF02867925
中图分类号
学科分类号
摘要
An unexpected increase in erythrocyte osmotic resistance during viral hepatitis in two patients prompted study of effects of hepatitis (in Karad) on osmotic resistance. The test was performed by placing erythrocytes in saline.solutions of decreasing osmolarity and osmotic fragility defined in terms of the saline concentration at which hemolysis : begins. Study included 44 infected subjects (acute viral hepatitis non-A non-B). All forty four infected subjects showed abnormal results when compared to normal subjects. Increased erythrocyte osmotic resistance i.e. hemolysis begins between 0.45% to 0.40% of NaCI and is completed between 0.25% to 0.20% NaCI, whereas in normal subjects hemolysis begins between 0.50% to 0.45% NaCI and is completed between 0.35% to 0.30% NaCI. Osmotic resistance was observed with increase in total bilirubin (mean ± SD) (4.6 ± 3.6), direct bilirubin (3.0 ± 2.5), SGOT (58.8 ± 55.5) SGPT (114.2 ± 150.3) activity. Physiologic shifts in erythrocyte osmotic resistance may be due to changes in membrane lipid ratio.
引用
收藏
页码:241 / 244
页数:3
相关论文
共 8 条
[1]  
Hillebrant C., Nyberg B.I., Einarsson K., Eriksson M.K., The effect of plasma LDL apheresis on the hepatic secretion of biliary lipids in humans, Gut, 41, 5, pp. 700-704, (1997)
[2]  
Cicodgnanic C., Malavoti M., Labate A., Lamboni L., Sama C., Barbara L., Serum lipid and lipoproein patterns in patients with liver cirrhosis and chronic acute hepatitis, Archives Internal. Med., 157, 7, pp. 792-796, (1997)
[3]  
Neerhont R.C., Abnormalities of erythrocyte stromal lipids in hepatic disease, J.Lab. Clin. Med., 71, pp. 438-440, (1968)
[4]  
Dacie J.V., Lewis S.M., Osmotic fragility of erythrocytes, Manual Procedures in Haematology and Coagulation, pp. 381-383, (1975)
[5]  
Ellis G., Goldbert D.M., Spooner R.J., Serum enzyme tests in disease of the liver and biliary tree, Amer. J. Clin. Pathol., 70, pp. 248-258, (1978)
[6]  
Perry B.W., Donmas B.T., Bayse D., A candidate reference method for determination of bilirubin in serum. Test for transformability, Clin. Chem, 29, pp. 297-301, (1983)
[7]  
Powell E., Kroon P., Liver lipoprotien and disease. 11 Clinical relevance of disordered cholesterol metabolism in liver disease, J. Gastroenterol. Hepatol., 7, pp. 225-231, (1992)
[8]  
Sherlock S., Dooleyd J., Chronic hepatitis, Diseases of the Liver and Biliary System, (1993)